PlainRecalls
FDA Drug Critical Class I Terminated

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

Reported: February 1, 2023 Initiated: December 6, 2022 #D-0183-2023

Product Description

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

Reason for Recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Details

Units Affected
209,292 capsules
Distribution
Nationwide in the USA.
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5. Recalled by Glaxosmithkline Consumer Healthcare Holdings DBA Haleon. Units affected: 209,292 capsules.
Why was this product recalled?
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2023. Severity: Critical. Recall number: D-0183-2023.